Eledon Pharmaceuticals, Inc. (ELDN) short interest & options flow
NASDAQEledon Pharmaceuticals approaches its May 19 Q1 earnings report with a notable shift in positioning: short sellers have been covering, the stock is up 26% in a month, and the borrow market remains undemanding — a setup that looks more constructive than punishing, even as the ORTEX short score holds elevated at 71. The most meaningful move in the lending market is the retreat in…
- Market cap
- $217M
- Next earnings
- 12 Nov 2026
Key data as of 12 Nov 2026

ELDN news and analysis
RSSNo long-form analysis yet for ELDN. Pulse alerts and the live data picture are available on ORTEX.
Open ELDN on ORTEX →Want the live picture for ELDN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ELDN — free to start on ORTEX.
Sign up for free →Open ELDN on ORTEX